Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20851499rdf:typepubmed:Citationlld:pubmed
pubmed-article:20851499lifeskim:mentionsumls-concept:C0019345lld:lifeskim
pubmed-article:20851499lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20851499lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:20851499lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:20851499lifeskim:mentionsumls-concept:C0041582lld:lifeskim
pubmed-article:20851499lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:20851499lifeskim:mentionsumls-concept:C0332237lld:lifeskim
pubmed-article:20851499lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:20851499lifeskim:mentionsumls-concept:C1522168lld:lifeskim
pubmed-article:20851499pubmed:issue4lld:pubmed
pubmed-article:20851499pubmed:dateCreated2011-3-18lld:pubmed
pubmed-article:20851499pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20851499pubmed:abstractTextPrior pilot studies support the use of antiviral medications with topical corticosteroids for herpes simplex labialis (HSL). ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL.lld:pubmed
pubmed-article:20851499pubmed:languageenglld:pubmed
pubmed-article:20851499pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20851499pubmed:citationSubsetIMlld:pubmed
pubmed-article:20851499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20851499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20851499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20851499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20851499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20851499pubmed:statusMEDLINElld:pubmed
pubmed-article:20851499pubmed:monthAprlld:pubmed
pubmed-article:20851499pubmed:issn1097-6787lld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:TyringStephen...lld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:LevinMyron...lld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:AokiFredFlld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:SpruanceSpots...lld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:DarpöBörjeBlld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:ArlanderEvaElld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:HullChristoph...lld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:BringJohanJlld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:HarmenbergJoh...lld:pubmed
pubmed-article:20851499pubmed:authorpubmed-author:ME-609...lld:pubmed
pubmed-article:20851499pubmed:copyrightInfoCopyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.lld:pubmed
pubmed-article:20851499pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20851499pubmed:volume64lld:pubmed
pubmed-article:20851499pubmed:ownerNLMlld:pubmed
pubmed-article:20851499pubmed:authorsCompleteYlld:pubmed
pubmed-article:20851499pubmed:pagination696.e1-11lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:meshHeadingpubmed-meshheading:20851499...lld:pubmed
pubmed-article:20851499pubmed:year2011lld:pubmed
pubmed-article:20851499pubmed:articleTitleEarly treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.lld:pubmed
pubmed-article:20851499pubmed:affiliationDepartment of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah 84132-2409, USA. Christopher.Hull@hsc.utah.edulld:pubmed
pubmed-article:20851499pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20851499pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20851499pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20851499pubmed:publicationTypeMulticenter Studylld:pubmed